In prostate cancer, TGFβ-driven transcription has been linked to bone metastasis through the activation of mTOR pathway [153], [154], [155] and TGFβ-dependent ALCAM expression drives bone metastasis [155]. The gene discussed is TGFB1; the disease is prostate carcinoma.